Ledger.Open graph →
SEC Form D · Amendment · filed August 11, 2011

CYLENE PHARMACEUTICALS, INC

Offering
$20.2M
Sold
$15.6M
Exemption
Industry
Biotechnology
Location
SAN DIEGO, CA
Type

People & firms on this filing (16)

Shaun A. Kirkpatrick · San Diego, CADirectorWilliam G. Rice, Ph.D · San Diego, CAExec · DirectorS. E. Torres · San Diego, CADirectorReinhard J. Ambros, Ph.D · San Diego, CADirectorFred A. Middleton · San Diego, CADirectorDaniel D. Von Hoff, M.D., F.A.C.P · San Diego, CADirectorPeter Feinstein · San Diego, CADirectorErich Platzer, M.D · San Diego, CADirectorPat Wood, Iii · Scottsdale, AZDirectorStephen Beaver · Scottsdale, AZDirectorJohn Goldberry · Scottsdale, AZDirectorTerrel Ross · Rockville Centre, NYDirectorRachel Sheinbein · FREMONT, CAExec · DirectorDavid Wright · Boulder, CODirectorGregory Halliday · Highland, UTDirectorCory Anderson · Danville, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗